CD274 and pneumonitis: Interestingly, pneumonitis was not a noted side effect in the anti-PD-L1 phase I trials (60, 62), but the 39% irAEs showed a distinct autoimmune-related trend: rash, hypothyroidism, hepatitis, plus isolated cases of diabetes mellitus, and myasthenia gravis, all mostly of grade 1–2 (62).